[Owen]

So I presume the writer profiled statistics from all countries, particularly those using Sputnik or Sinovac?

If not, why not?

[roving]

Ask him

[nickcarraway]

I’m sure they’d like to, but it costs a lot of money, and it’s hard to get funding outside the pharmaceutical industry.